Myrtelle Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-027/2/26 | New | $16,700,000 | $16,700,000 | Debt Only | 06b | SEC linkSEC |
| 2025-12-2312/23/25 | New | $30,531,749 | $30,531,749 | Equity Only | 06b | SEC linkSEC |
| 2025-03-213/21/25 | New | $7,485,000 | $7,485,000 | Debt Only | 06b | SEC linkSEC |
| 2024-06-106/10/24 | New | $6,040,000 | $6,040,000 | Debt Only | 06b | SEC linkSEC |
| 2022-10-1710/17/22 | New | $15,684,004 | $15,684,004 | Equity Only | 06b | SEC linkSEC |
| 2021-07-087/8/21 | Amended | $13,500,000 | Unknown | Equity Only | SEC linkSEC | |
| 2021-06-246/24/21 | New | $13,500,000 | $13,500,000 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Thomas Barton | Director |
| Chrystyna Bedrij | Director |
| James Huang | Director |
| Michael Muhonen | Director |
| Laurie Platek | Director |
| Laurie Playtek | Executive |
| Mark Pykett | Director, Executive |
| Adrian Stecyk | Director, Executive |
| Fay Xing | Director |
| Debra Yu | Director |
Industry: Biotechnology (See others in industry)
Address:
17 State Street Fl3, Suite 350
New York, NY, 10004
Phone: (781) 621-2381
New York, NY, 10004
Phone: (781) 621-2381